On 12 April 2010 JSC “Grindeks” has received the notification on obtaining significant holding from OJSC “Pharmstandart”. “Pharmstandart’s” total holdings in the security of JSC “Grindeks” currently amount to 11.3 % of the outstanding shares.

“Grindeks” Chairman of the Board Janis Romanovskis: “OJSC “Pharmstandart” is the leading Russian pharmaceutical company and since 2008 is one of the most important cooperation partners of “Grindeks” that promotes and sells our brand product Mildrontate®. OJSC “Pharmstandart” as one of the biggest shareholders of “Grindeks” will strengthen our positions in Russia and provide new business opportunities.”

In the attachment: Notification from “Pharmstandart” on 4 (four) pages.

Further information:
Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
e-mail: laila.klavina@grindeks.lv